Suppressing the SREBP-mediated lipogenic pathway rescues pink1 deficiency in Drosophila and influences mitochondrial morphology.

Authors

Jenny Zhe Liao, Christopher Tam, Esther M Verheyen

Published in

Journal of cell science. Oct 28, 2026. Epub Oct 28, 2026.

Abstract

Sterol-regulatory element binding proteins (SREBP) are master transcriptional factors controlling lipogenesis. In Drosophila, the SREBP-mediated lipogenic pathway is essential for development. Homozygous SREBP mutants are lipid deficient and larval lethal, whereas excessive lipids in flies are often associated with neurodegeneration. Since SREBP has previously been identified as a risk factor for Parkinson's disease, we further investigated the role of SREBP-mediated lipogenesis in a pink1 deficient Drosophila parkinsonism model. We found that expressing either dominant negative SREBP or knocking down its downstream target rescues pink1 mutant phenotypes including thorax indentation and impaired locomotion. Investigation of the indirect flight muscles reveals that suppression of the lipogenic pathway restores defective muscle morphology and mitochondrial defects, and reduces ectopic ROS associated with the pink1 null allele. Interestingly, we found altered mitochondrial morphologies when the lipogenic pathway was manipulated under physiological condition, suggesting the SREBP-mediated lipogenic pathway plays a role in regulating mitochondrial shapes. Our findings highlight the tight connection between lipid metabolism and mitochondria in both disease and physiological setting.

PMID:
42947660
Bibliographic data and abstract were imported from PubMed on 28 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.